
Mahmoud Fatahi Yar
Examiner (ID: 19180)
| Most Active Art Unit | 2609 |
| Art Unit(s) | 2609, 2604, 2629, 2774, 2674, 2899, 2606 |
| Total Applications | 600 |
| Issued Applications | 471 |
| Pending Applications | 2 |
| Abandoned Applications | 127 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15254625
[patent_doc_number] => 20190376046
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-12
[patent_title] => METHODS FOR MANIPULATING CELL FATE
[patent_app_type] => utility
[patent_app_number] => 16/483107
[patent_app_country] => US
[patent_app_date] => 2018-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31605
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16483107
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/483107 | METHODS FOR MANIPULATING CELL FATE | Feb 1, 2018 | Abandoned |
Array
(
[id] => 16547951
[patent_doc_number] => 10881086
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-05
[patent_title] => Genetically modified mouse whose genome comprises a humanized CD274 gene
[patent_app_type] => utility
[patent_app_number] => 15/883477
[patent_app_country] => US
[patent_app_date] => 2018-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 6
[patent_no_of_words] => 28976
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15883477
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/883477 | Genetically modified mouse whose genome comprises a humanized CD274 gene | Jan 29, 2018 | Issued |
Array
(
[id] => 12806476
[patent_doc_number] => 20180160662
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-14
[patent_title] => Transgenic Immunodeficient Mouse Expressing Human SIRP-alpha
[patent_app_type] => utility
[patent_app_number] => 15/880513
[patent_app_country] => US
[patent_app_date] => 2018-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12838
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15880513
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/880513 | Transgenic Immunodeficient Mouse Expressing Human SIRP-alpha | Jan 24, 2018 | Abandoned |
Array
(
[id] => 15143401
[patent_doc_number] => 20190350178
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-21
[patent_title] => ANIMAL MODEL FOR DRUG DEVELOPMENT
[patent_app_type] => utility
[patent_app_number] => 16/479501
[patent_app_country] => US
[patent_app_date] => 2018-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13366
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16479501
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/479501 | ANIMAL MODEL FOR DRUG DEVELOPMENT | Jan 21, 2018 | Abandoned |
Array
(
[id] => 14625243
[patent_doc_number] => 20190225989
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-25
[patent_title] => GENE KNOCKIN METHOD AND KIT FOR GENE KNOCKIN
[patent_app_type] => utility
[patent_app_number] => 15/874904
[patent_app_country] => US
[patent_app_date] => 2018-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11375
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15874904
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/874904 | GENE KNOCKIN METHOD AND KIT FOR GENE KNOCKIN | Jan 18, 2018 | Abandoned |
Array
(
[id] => 14731855
[patent_doc_number] => 10385318
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-20
[patent_title] => Method of making a population of chondrocytes from reprogrammed chondrocytes
[patent_app_type] => utility
[patent_app_number] => 15/872577
[patent_app_country] => US
[patent_app_date] => 2018-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11389
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15872577
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/872577 | Method of making a population of chondrocytes from reprogrammed chondrocytes | Jan 15, 2018 | Issued |
Array
(
[id] => 15145015
[patent_doc_number] => 20190350985
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-21
[patent_title] => Methods of Treating Brain Injury Using Cord Blood or a Component Thereof
[patent_app_type] => utility
[patent_app_number] => 16/477110
[patent_app_country] => US
[patent_app_date] => 2018-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11097
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16477110
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/477110 | Methods of Treating Brain Injury Using Cord Blood or a Component Thereof | Jan 11, 2018 | Pending |
Array
(
[id] => 15931725
[patent_doc_number] => 20200157496
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-21
[patent_title] => METHOD OF DIFFERENTIATING HAIR FOLLICLE CELL INTO GERMLINE STEM CELL AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/476891
[patent_app_country] => US
[patent_app_date] => 2018-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7673
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16476891
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/476891 | Method of transdifferentiating hair follicle stem cells into sperm stem cells | Jan 8, 2018 | Issued |
Array
(
[id] => 18367594
[patent_doc_number] => 11647737
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-16
[patent_title] => Genetically modified rabbit expressing an exogenous protein in milk
[patent_app_type] => utility
[patent_app_number] => 16/475127
[patent_app_country] => US
[patent_app_date] => 2017-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 7694
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16475127
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/475127 | Genetically modified rabbit expressing an exogenous protein in milk | Dec 28, 2017 | Issued |
Array
(
[id] => 16235941
[patent_doc_number] => 20200253175
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-13
[patent_title] => COLD-RESISTANT AND LEAN-TYPE TRANSGENIC PIG AND PREPARATION METHOD THEREFOR
[patent_app_type] => utility
[patent_app_number] => 16/612142
[patent_app_country] => US
[patent_app_date] => 2017-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3494
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16612142
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/612142 | Cold-resistant and lean-type transgenic pig and preparation method therefor | Dec 28, 2017 | Issued |
Array
(
[id] => 15145197
[patent_doc_number] => 20190351076
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-21
[patent_title] => TUMOR CELL XENOGRAFT MODEL IN ZEBRAFISH, AND METHODS OF CONSTRUCTING AND USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/475793
[patent_app_country] => US
[patent_app_date] => 2017-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5764
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16475793
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/475793 | TUMOR CELL XENOGRAFT MODEL IN ZEBRAFISH, AND METHODS OF CONSTRUCTING AND USING THE SAME | Dec 26, 2017 | Abandoned |
Array
(
[id] => 14496021
[patent_doc_number] => 20190191665
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => SYSTEM AND METHOD OF MEASURED DRUG EFFICACY USING NON-INVASIVE TESTING
[patent_app_type] => utility
[patent_app_number] => 15/851222
[patent_app_country] => US
[patent_app_date] => 2017-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10397
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 185
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15851222
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/851222 | SYSTEM AND METHOD OF MEASURED DRUG EFFICACY USING NON-INVASIVE TESTING | Dec 20, 2017 | Abandoned |
Array
(
[id] => 13372411
[patent_doc_number] => 20180237746
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-23
[patent_title] => Multipotential Expanded Mesenchymal Precursor Cell Progeny (MEMP) and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 15/847009
[patent_app_country] => US
[patent_app_date] => 2017-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20387
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15847009
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/847009 | Multipotential Expanded Mesenchymal Precursor Cell Progeny (MEMP) and Uses Thereof | Dec 18, 2017 | Abandoned |
Array
(
[id] => 12656926
[patent_doc_number] => 20180110808
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-26
[patent_title] => METHODS AND COMPOSITIONS FOR THE TREATMENT OF LYSOSOMAL STORAGE DISEASES
[patent_app_type] => utility
[patent_app_number] => 15/840904
[patent_app_country] => US
[patent_app_date] => 2017-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21386
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15840904
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/840904 | Methods and compositions for the treatment of lysosomal storage diseases | Dec 12, 2017 | Issued |
Array
(
[id] => 12808603
[patent_doc_number] => 20180161371
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-14
[patent_title] => ENGINEERED NATURAL KILLER CELLS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/837576
[patent_app_country] => US
[patent_app_date] => 2017-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43368
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15837576
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/837576 | Method of treating multiple myeloma using natural killer cells expressing a chimeric antigen receptor for CD38 | Dec 10, 2017 | Issued |
Array
(
[id] => 15083453
[patent_doc_number] => 20190336537
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-07
[patent_title] => GENERATING ATRIAL AND VENTRICULAR CARDIOMYOCYTE LINEAGES FROM HUMAN PLURIPOTENT STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 16/466278
[patent_app_country] => US
[patent_app_date] => 2017-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17850
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -44
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16466278
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/466278 | GENERATING ATRIAL AND VENTRICULAR CARDIOMYOCYTE LINEAGES FROM HUMAN PLURIPOTENT STEM CELLS | Dec 3, 2017 | Abandoned |
Array
(
[id] => 15553425
[patent_doc_number] => 20200061124
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-27
[patent_title] => METHODS FOR MAKING AND USING DEDIFFERENTIATED AND STEM-LIKE HUMAN CELLS
[patent_app_type] => utility
[patent_app_number] => 16/467365
[patent_app_country] => US
[patent_app_date] => 2017-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12717
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16467365
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/467365 | METHODS FOR MAKING AND USING DEDIFFERENTIATED AND STEM-LIKE HUMAN CELLS | Nov 30, 2017 | Abandoned |
Array
(
[id] => 15019257
[patent_doc_number] => 20190320633
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-24
[patent_title] => HUMANIZED MOUSE MODEL WITH IMPROVED HUMAN INNATE IMMUNE CELL DEVELOPMENT
[patent_app_type] => utility
[patent_app_number] => 16/465006
[patent_app_country] => US
[patent_app_date] => 2017-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23987
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16465006
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/465006 | HUMANIZED MOUSE MODEL WITH IMPROVED HUMAN INNATE IMMUNE CELL DEVELOPMENT | Nov 29, 2017 | Abandoned |
Array
(
[id] => 14199501
[patent_doc_number] => 10266847
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-23
[patent_title] => Methods of delivering a pseudotyped lentivirus
[patent_app_type] => utility
[patent_app_number] => 15/820741
[patent_app_country] => US
[patent_app_date] => 2017-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 35
[patent_no_of_words] => 29376
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15820741
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/820741 | Methods of delivering a pseudotyped lentivirus | Nov 21, 2017 | Issued |
Array
(
[id] => 12791533
[patent_doc_number] => 20180155680
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-07
[patent_title] => ESTABLISHING PLURIPOTENCY IN MOUSE EMBRYONIC STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 15/821645
[patent_app_country] => US
[patent_app_date] => 2017-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10442
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15821645
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/821645 | ESTABLISHING PLURIPOTENCY IN MOUSE EMBRYONIC STEM CELLS | Nov 21, 2017 | Abandoned |